АПФЕЛЬБАУМ, Рахель (US),ОХ, Йоон (US),ПИТ, Эндрю Джеймс (US)
申请号：
RU2018123711
公开号：
RU2018123711A
申请日:
2016.11.30
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
The present invention relates to an improved formulation of danirixin in its hydrobromide salt form. This improved formulation can be an aqueous intravenous formulation containing danirixin or a lyophilized pharmaceutical solid composition containing danirixin to be reconstituted to provide a solution for intravenous administration.
